Physician profile
M Rohi Atassi
NPI 1467816397
$2,122.93
in general payments reported to CMS, 2019-2025
13 companies · $514 in 2025
The $514 reported for 2025 was more than what 91% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $191 · 2021: $288 · 2022: $69.03 · 2023: $99.24 · 2024: $780 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544 · Honoraria: $500 · Education: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.62 |
| Honoraria | $500.00 |
| Education | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $737.08 | 2020-2025 | Invisalign, Invisalign First - Comprehensive, Invisalign Go |
| Bisco, INC. | $500.00 | 2024 | |
| Zimvie INC. | $208.15 | 2024-2025 | |
| Straumann USA LLC | $192.61 | 2019-2023 | |
| Biohorizons Implant Systems INC. | $142.38 | 2021 | |
| Geistlich Pharma, North America, INC. | $74.36 | 2025 | Biomaterials |
| Dentsply Sirona INC | $71.42 | 2024 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Henry Schein, INC. | $62.50 | 2024 | |
| Biolase, INC. | $55.01 | 2022 | |
| 3m Company | $35.95 | 2020-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.16 | 2021 | |
| Philips North America LLC | $14.02 | 2022 | |
| Ultradent Products INC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Rohi Atassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.